Vontobel Holding Ltd. Has $1.83 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Vontobel Holding Ltd. trimmed its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 11.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,362 shares of the company’s stock after selling 2,875 shares during the period. Vontobel Holding Ltd.’s holdings in HealthEquity were worth $1,830,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. International Assets Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter worth $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity during the third quarter worth $39,000. Fidelis Capital Partners LLC bought a new position in HealthEquity in the first quarter valued at about $42,000. GAMMA Investing LLC increased its position in HealthEquity by 114.8% in the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity during the 2nd quarter worth about $73,000. 99.55% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HQY has been the subject of several analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Finally, Bank of America cut their target price on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus price target of $103.83.

HealthEquity Trading Down 0.4 %

NASDAQ:HQY opened at $87.68 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The business’s 50-day simple moving average is $78.75 and its 200-day simple moving average is $79.47. HealthEquity, Inc. has a fifty-two week low of $61.81 and a fifty-two week high of $89.08. The stock has a market capitalization of $7.63 billion, a PE ratio of 95.30, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. Sell-side analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,497 shares of company stock valued at $3,579,769. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.